TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02710266

Evaluation of the Effect of Gabexate Mesilate in the Hepatocyte Protection After Liver Resection

Cause of deathSlow enrollment Automatic label, confidence 0.5, unverified. How labels are made.
“This study was closed earlier than planned because targeted participant recruitment is not smooth.”

The sponsor’s own words in the registry.

Life of this trial

2012201320142015201620172018Started2012-02-24Registered2016-02-01Stopped2017-02-25

Vital statistics

Status
Terminated
Phase
Phase 3
Sponsor
Yonsei University
Sponsor type
University, hospital or other
Conditions
Liver Disease
Interventions
Preoperative Gabexate Mesilate group; Intraoperative Gabexate Mesilate group; hepatectomy with dextrose water
Participants
2
Sites
1
Countries
South Korea

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.